Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.

Toxins (Basel) · 2019 · PMC6891305 · PMID 31689912

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Although the prevalence has shown an increasing trend in recent years [ 4 ], the treatment of patients with IC/BPS remains challenging for urologists.

also in 63,971 other papers

did not reach statistical significanceno p-value reported

Symptomatic improvement among injections did not reach statistical significance, particularly in terms of incontinence episodes and voided volume.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.